TNGX
Tango Therapeutics Inc

604
Loading...
Loading...
Tango Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in discovering and delivering precision cancer medicines. It also identifies novel targets and develops new drugs directed at tumor suppressor gene loss in defined patient populations with high unmet medical need. The company was founded by Alan Ashworth, William G. Kaelin Jr., Jose Baselga, and Antoni Ribas in 2017 and is headquartered in Boston, MA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
155

Frequently Asked Questions

What is Market Cap of Tango Therapeutics Inc?
What is the 52-week high for Tango Therapeutics Inc?
What is the 52-week low for Tango Therapeutics Inc?
What is Tango Therapeutics Inc stock price today?
What was Tango Therapeutics Inc stock price yesterday?
What is the PE ratio of Tango Therapeutics Inc?
What is the Price-to-Book ratio of Tango Therapeutics Inc?
What is the 50-day moving average of Tango Therapeutics Inc?
How many employess does Tango Therapeutics Inc has?

Latest TNGX News

View

Advertisement. Remove ads.

Advertisement. Remove ads.